TY - JOUR
T1 - Synthesis and biological evaluation of some heterocyclic scaffolds based on the multifunctional N-(4-acetylphenyl)-2-chloroacetamide
AU - Abdel-Latif, Ehab
AU - Fahad, Mustafa M.
AU - El-Demerdash, Amr
AU - Ismail, Mohamed A.
N1 - Publisher Copyright:
© 2020 Wiley Periodicals LLC.
PY - 2020/8/1
Y1 - 2020/8/1
N2 - The chloroacetamide derivative, 1, was used as a versatile precursor for the synthesis of various types of N-aryl-2-(benzothiazol-2-ylthio)acetamide derivatives. The reaction of 1 with 2-mercaptobenzothiazole followed by condensation reaction of the produced sulfide with phenylhydrazine, 2-cyanoacetohydrazide, and/or thiosemicarbazide furnished the conforming condensation products, 4, 7, and 10, respectively. Treatment of the phenylhydrazone product, 4, with Vilsmeier formylation reagent (POCl3/DMF) yielded the corresponding 4-formylpyrazole derivative, 5. The thiosemicarbazone product, 10, was reacted with ethyl bromoacetate to furnish the thiazolin-4-one derivative, 11. The substitution reactions of chloroacetamide derivative, 1, with 2-mercapto-4,6-dimethylnicotinonitrile and 6-amino-2-mercaptopyrimidin-4-ol, were explored to identify the sulfide products, 14 and 17. Cyclization of 14 into its corresponding thieno[2,3-b]pyridine compound, 15, was performed using sodium ethoxide. The thiosemicarbazone, 10, and sulfide derivative, 14, were found to be the most potent antibacterial compounds against Escherichia coli and Staphylococcus aureus, exhibiting growth inhibitory activities of 80.8% and 91.7%, respectively. Moreover, the thiosemicarbazone, 10, displayed the most significant antioxidant activity with inhibitory activity of 82.6%, which comes close to the antioxidant activity of L-ascorbic acid.
AB - The chloroacetamide derivative, 1, was used as a versatile precursor for the synthesis of various types of N-aryl-2-(benzothiazol-2-ylthio)acetamide derivatives. The reaction of 1 with 2-mercaptobenzothiazole followed by condensation reaction of the produced sulfide with phenylhydrazine, 2-cyanoacetohydrazide, and/or thiosemicarbazide furnished the conforming condensation products, 4, 7, and 10, respectively. Treatment of the phenylhydrazone product, 4, with Vilsmeier formylation reagent (POCl3/DMF) yielded the corresponding 4-formylpyrazole derivative, 5. The thiosemicarbazone product, 10, was reacted with ethyl bromoacetate to furnish the thiazolin-4-one derivative, 11. The substitution reactions of chloroacetamide derivative, 1, with 2-mercapto-4,6-dimethylnicotinonitrile and 6-amino-2-mercaptopyrimidin-4-ol, were explored to identify the sulfide products, 14 and 17. Cyclization of 14 into its corresponding thieno[2,3-b]pyridine compound, 15, was performed using sodium ethoxide. The thiosemicarbazone, 10, and sulfide derivative, 14, were found to be the most potent antibacterial compounds against Escherichia coli and Staphylococcus aureus, exhibiting growth inhibitory activities of 80.8% and 91.7%, respectively. Moreover, the thiosemicarbazone, 10, displayed the most significant antioxidant activity with inhibitory activity of 82.6%, which comes close to the antioxidant activity of L-ascorbic acid.
UR - http://www.scopus.com/inward/record.url?scp=85085661226&partnerID=8YFLogxK
U2 - 10.1002/jhet.4012
DO - 10.1002/jhet.4012
M3 - Article
AN - SCOPUS:85085661226
VL - 57
SP - 3071
EP - 3081
JO - Journal of Heterocyclic Chemistry
JF - Journal of Heterocyclic Chemistry
SN - 0022-152X
IS - 8
ER -